Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acquired immunodeficiency syndrome
adverse drug reaction
antiemetic
anxiety
automobile accidents
bent spine syndrome
camptocormia
CAT scan
CAT scan, abnormal
CAT scan, muscle
catatonia
compazine
conversion reaction
creatine phosphokinase(CPK)elevated
depression
drug induced neurologic disorders
dystonia
dystonia, post traumatic
dystonia, psychogenic
dystonia, treatment of
electromyogram
familial
head injury
iatrogenic neurologic disorders
kyphosis
low back pain
medical-legal aspects of neurology
metoclopramide
misdiagnosis
movement disorder
movement disorder, extrapyramidal
movement disorder, psychogenic
muscle biopsy
muscle weakness
muscular dystrophy
myasthenia gravis
myoclonus
myopathy
myopathy, metabolic
old age, neurology of
paraspinal muscle
paraspinal muscle weakness
Parkinson disease
Parkinson disease, misdiagnosis
Parkinson disease, psychogenic
Parkinsonism syndrome
postural abnormality
prognosis
psychiatric disorder
psychiatric problems in neurologic disorders
reflex sympathetic dystrophy
renal failure
review article
stooped posture
stress, emotional
torticollis
torticollis, post traumatic
trauma
treatment of neurologic disorder
tremor
tremor, post traumatic
tremor, psychogenic
tremor, treatment of
weakness, progressive
Showing articles 300 to 350 of 1533 << Previous Next >>

Practice Parameter: Diagnosis and Prognosis of New Onset Parkinson Disease (An Evidence-Based Review)
Neurol 66:968-975, Suchowersky,O.,et al, 2006

The Parkinsons Complex: Parkinsonism Is Just the Tip of the Iceberg
Ann Neurol 59:591-596, Langston,J.W., 2006

Practice Parameter: Neuroprotective Strategies and Alternative Therapies for Parkinson Disease (An Evidence-Based Review)
Neurol 66:976-982, Suchowersky,O.,et al, 2006

Safety of Rasagiline in Elderly Patients with Parkinson Disease
Neurol 66:1427-1429, Goetz,C.G.,et al, 2006

Dopa-responsive Dystonic Camptocormia
Neurol 66:1779, Van Gerpen,J.A., 2006

Prospective Prevalence of Pathologic Gambling and Medication Association in Parkinson Disease
Neurol 66:1750-1752, Voon,V.,et al, 2006

Ictal Eye Closure is a Reliable Indicator for Psychogenic Nonepileptic Seizures
Neurol 66:1730-1731, Chung,S.S.,et al, 2006

Diagnosis of Psychogenic Nonepileptic Status Epilepticus in the Emergency Setting
Neurol 66:1727-1729, Holtkamp,M.,et al, 2006

Pesticide Exposure and Risk for Parkinsons Disease
Ann Neurol 60:197-203, Ascherio,A.,et al, 2006

A Randomized Trial of Deep-Brain Stimulation for Parkinsons Disease
NEJM 355:896-908, Deuschl,G.,et al, 2006

Clinicopath Conf, Dopamine-Responsive-Dystonia Caused by a Mutation in the GCH1 Gene
NEJM 355:831-839, Case 26-2006, 2006

Dystonia
NEJM 355:818-829, Tarsy,D. &Simon,D.K., 2006

Reversible Dementia with Parkinsonian Features Associated with Budesonide Use
Neurol 67:723, Proda,C.I.,et al, 2006

Atypical Antipsychotics in the Elderly with Parkinson Disease and the "Black Box" Warning
Neurol 67:564-566, Friedman,J.H., 2006

Common Misdiagnosis of a Common Neurological Disorder: How Are We Misdiagnosing Essential Tremor?
Arch Neurol 63:1100-1104, Jain,S.,et al, 2006

Collaborative Analysis of a-Synuclein Gene Promotor Variability and Parkinson Disease
JAMA 296:661-670, Maraganore,D.M.,et al, 2006

Parkinsons Disease and Genetics
The Neurologist 12:240-244, Lester,J.&Otero-Siliceo,E., 2006

Genetics of Parkinsons Disease and Parkinsonism
Ann Neurol 60:389-398, Hardy,J.,et al, 2006

Impaired Visual Search in Drivers with Parkinsons Disease
Ann Neurol 60:407-413,387, Uc,E.Y.,et al, 2006

Parkinsons Disease with Camptocormia
JNNP 77:1223-1228,1205, Bloch,F.,et al, 2006

Dopamine Agonists and Cardiac Valvulopathy in Parkinson Disease: A Case-Control Study
Neurol 67:1225-1229, Yamamoto,M.,et al, 2006

Brain Metal Concentrations in Chronic Liver Failure Patients With Pallidal T1 MRI Hyperintensity
Neurol 67:1984-1989, Klos,K.J.,et al, 2006

Unexplained Neurologic Symptoms: An fMRI Study of Sensory Conversion Disorder
Neurol 67:2036-2038,1914, Ghaffar,O.,et al, 2006

Quantatative Assessment of Driving Performance in Parkinson's Disease
JNNP 76:176-180, 159, Wood, J.M., et al, 2005

Genetic Screening for a Single Common LRRK2 Mutation in Familial Parkinson's Disease
Lancet 365:410-412, Nichols, W.C., et al, 2005

A Randomized Placebo-Controlled Trial of Rasagiline in Levodopa-Treated Patients with Parkinson Disease and Motor Fluctuations
Arch Neurol 62:241-248, The PRESTO Study, 2005

Rasagiline as an Adjunct to Levodopa in Patients With Parkinsons Disease and Motor Fluctuations (LARGO, Lasting Effect in Adjunct Therapy With Rasagiline Given Once Daily, Study)
Lancet 365:947-954, 914, Rascol,O., et al, 2005

The role of radiotracer imaging in Parkinson disease
Neurol 64:208-215, Ravina, B., et al, 2005

Amorphine-induced eosinophilic panniculitis and hypereosinophilia in Parkinson disease
Neurol 64:392-393, Pot, C., et al, 2005

Pallidal vs Subthalamic Nucleus Deep Brain Stimulation in Parkinson Disease
Arch Neurol 62:554-560,533, Anderson,V.C.,et al, 2005

Donepezil for Dementia in Parkinsons Disease: A Randomised, Double Blind, Placebo Controlled, Crossover Study
JNNP 76:934-939,903, Ravina,B.,et al, 2005

Short-Term Paroxetine Treatment Does Not Alter the Motor Response to Levodopa in PD
Neurol 64:1797-1798, Chung,K.A.,et al, 2005

[99mTc]TRODAT-1 SPECT Imaging Correlates with Odor Identification in Early Parkinson Disease
Neurol 64:1716-1720, Siderowf,A.,et al, 2005

Searching for a Relationship Between Manganese and Welding and Parkinsons Disease
Neurol 64:2021-2028, 2001, Jankovic,J., 2005

Neurologic Manifestations in Welders with Pallidal MRI T1 Hyperintensity
Neurol 64:2033-2039,2001, Josephs,K.A.,et al, 2005

New and Reliable MRI Diagnosis for Progressive Supranuclear Palsy
Neurol 64:2050-2055, Oba,H.,et al, 2005

Pleuropulmonary Fibrosis After Long-term Treatment With the Dopamine Agonist Pergolide for Parkinson Disease
Arch Neurol 62:1290-1295, Tintner,R.,et al, 2005

Sudden Uncontrollable Somnolence and Medication Use in Parkinson Disease
Arch Neurol 62:1242-1248, Avorn,J.,et al, 2005

Camptocormia
Neurol 65:355-359, Azher,S.N. &Jankovic,J., 2005

Initial Diagnoses Given to Persons with the Fragile X Associated Tremor/Ataxia Syndrome (FXTAS)
Neurol 65:299-301, Hall,D.A.,et al, 2005

Diagnosis and Initial Management of Parkinsons Disease
NEJM 353:1021-1027, Nutt,J.G.&Wooten,G.F., 2005

Use of Serum Prolactin in Diagnosing Epileptic Seizures
Neurol 65:668-675, Chen,D.K.,et al, 2005

Science and Ethics of Sham Surgery, A Survey of Parkinson Disease Clinical Researchers
Arch Neurol 62:1357-1360,1343, Kim,S.Y.H.,et al, 2005

Neurologic Spectrum of Chronic Liver Failure and Basal Ganglia T1 Hyperintensity on Magnetic Resonance Imaging, Probably Manganese Neurotoxicity
Arch Neurol 62:1385-1390, Klos,K.J.,et al, 2005

Pathological Gambling Caused by Drugs Used to Treat Parkinson Disease
Arch Neurol 62:1377-1381, Dodd,M.L.,et al, 2005

Neuropathology of Dementia in Parkinsons Disease: A Prospective, Community-Based Study
Ann Neurol 58:773-776,663, Aarsland,D.,et al, 2005

Systematic Review of Misdiagnosis of Conversion Symptoms and "Hysteria"
BMJ 331:989-991,978, Stone,J.,et al, 2005

Cabergoline-Related Severe Restrictive Mitral Regurgitation
NEJM 353:1974-1975, Rosen,C.J., 2005

Occupation and Parkinsonism in Three Movement Disorders Clinics
Neurol 65:1430-1435, Goldman,S.M.,et al, 2005

Excessive Daytime Sleepiness and Subsequent Development of Parkinson Disease
Neurol 65:1442-1446, Abbott,R.D.,et al, 2005



Showing articles 300 to 350 of 1533 << Previous Next >>